Tema Etfs LLC Takes $2.34 Million Position in Cardinal Health, Inc. $CAH

Tema Etfs LLC purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAHFree Report) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 14,905 shares of the company’s stock, valued at approximately $2,339,000.

A number of other hedge funds have also recently added to or reduced their stakes in CAH. Integrated Wealth Concepts LLC raised its position in shares of Cardinal Health by 6.9% during the first quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock worth $601,000 after purchasing an additional 280 shares during the period. Jones Financial Companies Lllp increased its stake in Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares in the last quarter. Strs Ohio acquired a new position in shares of Cardinal Health during the first quarter valued at about $2,652,000. Harbor Investment Advisory LLC increased its position in shares of Cardinal Health by 25.0% during the second quarter. Harbor Investment Advisory LLC now owns 751 shares of the company’s stock worth $126,000 after acquiring an additional 150 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. raised its holdings in shares of Cardinal Health by 7.9% in the 2nd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,074 shares of the company’s stock worth $181,000 after acquiring an additional 79 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Stock Performance

NYSE CAH opened at $202.42 on Tuesday. The company has a market capitalization of $48.10 billion, a PE ratio of 30.53, a price-to-earnings-growth ratio of 1.46 and a beta of 0.65. Cardinal Health, Inc. has a 52-week low of $119.25 and a 52-week high of $214.93. The company has a 50-day simple moving average of $204.29 and a 200 day simple moving average of $173.48.

Cardinal Health (NYSE:CAHGet Free Report) last issued its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.22 by $0.33. The company had revenue of $64.01 billion during the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. Cardinal Health’s quarterly revenue was up 22.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be paid a $0.5107 dividend. The ex-dividend date is Friday, January 2nd. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio (DPR) is presently 30.77%.

Wall Street Analysts Forecast Growth

CAH has been the subject of a number of recent research reports. TD Cowen boosted their price objective on Cardinal Health from $183.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, November 3rd. Weiss Ratings reissued a “buy (b)” rating on shares of Cardinal Health in a research report on Wednesday, October 8th. Evercore ISI raised their price objective on Cardinal Health from $190.00 to $220.00 and gave the company an “outperform” rating in a research note on Friday, October 31st. Robert W. Baird set a $232.00 target price on shares of Cardinal Health in a report on Friday, October 31st. Finally, Leerink Partners boosted their price target on shares of Cardinal Health from $211.00 to $230.00 and gave the stock an “outperform” rating in a report on Monday, November 17th. Fourteen equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $213.40.

Read Our Latest Analysis on Cardinal Health

Cardinal Health Profile

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Featured Stories

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.